{"gene":"PF3D7_1115700","run_date":"2026-09-08T12:51:28","timeline":{"discoveries":[{"year":2000,"finding":"FP2A (falcipain-2) is the principal trophozoite cysteine protease of P. falciparum, responsible for at least 93% of trophozoite soluble cysteine protease activity; it is concentrated in food vacuoles, hydrolyzes both native hemoglobin and denatured globin optimally at acid pH in a reducing environment, and can initiate cleavage of native hemoglobin.","method":"Affinity chromatography purification of native enzyme; recombinant expression in E. coli with refolding; enzymatic assays against peptide substrates, native hemoglobin, and denatured globin; immunolocalization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — purification of native enzyme plus recombinant reconstitution, multiple orthogonal methods (activity assay, localization, substrate assay), replicated by subsequent studies","pmids":["10887194"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2004,"finding":"Genetic disruption of the FP2A gene in P. falciparum causes markedly diminished trophozoite cysteine protease activity and swollen, hemoglobin-filled food vacuoles, confirming FP2A's specific role in hemoglobin hydrolysis during the trophozoite stage; knockout parasites showed increased sensitivity to cysteine and aspartic protease inhibitors, revealing cooperative action between cysteine and aspartic proteases in hemoglobin degradation.","method":"Gene disruption (knockout) by homologous recombination; morphological analysis; cysteine protease activity assay; drug sensitivity assays (E-64, leupeptin, pepstatin)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple orthogonal readouts, replicated in a subsequent study (PMID:16890302)","pmids":["15070727"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"finding":"Disruption of the FP2A gene in the 3D7 strain produced swollen hemoglobin-filled food vacuoles in trophozoites; FP2A knockout parasites were twice as sensitive to cysteine protease inhibitors and over 1000-fold more sensitive to an aspartic protease inhibitor compared to wild-type, further supporting FP2A's role in hemoglobin hydrolysis and the cooperative interplay between cysteine and aspartic proteases.","method":"Gene disruption in 3D7 strain; morphological analysis; drug sensitivity assays","journal":"Molecular and biochemical parasitology","confidence":"High","confidence_rationale":"Tier 2 / Strong — independent replication of KO phenotype in defined strain with quantitative drug sensitivity readouts","pmids":["16890302"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"}]},{"year":2005,"finding":"FP2A possesses a unique 14-amino acid C-terminal beta-hairpin motif (FP2(arm)) that mediates binding to hemoglobin independent of the active site; deletion of 10 residues of this motif abolishes activity against hemoglobin and globin but not against peptide substrates, casein, or gelatin. This motif also mediates interaction with the prodomain inhibitor of FP2A.","method":"Site-directed mutagenesis (deletion mutant Delta10FP2A); enzymatic assays against peptide substrates, hemoglobin, globin, casein, gelatin; E-64-inhibited complex pulldown to assess hemoglobin binding; peptide competition assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — active-site independent binding demonstrated by mutagenesis plus multiple substrate/binding assays in a single rigorous study","pmids":["15964982"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"finding":"Crystal structure of mature FP2A at 3.1 Å resolution reveals a dynamic beta-hairpin hemoglobin-binding motif (FP2(arm)), a flexible N-terminal alpha-helical extension, and a unique active-site cleft. Biochemical assays showed that mature FP2A can proteolytically process its own precursor in trans at neutral to weakly alkaline pH, that hemoglobin binding is strictly pH-dependent, and that FP2A preferentially binds methemoglobin over hemoglobin.","method":"X-ray crystallography (3.1 Å); biochemical processing assays; hemoglobin-binding assays under varying pH conditions","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure combined with functional biochemical assays in a single study","pmids":["16777845"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"finding":"Crystal structure of FP2A in complex with the protease inhibitor cystatin at 2.9 Å reveals two unique structural motifs: FP2(nose), a short N-terminal segment required for folding without a prodomain, and FP2(arm), required for hemoglobinase activity. Mutagenesis of two Tyr within FP2(nose) and a conserved Glu outside it confirmed their functional roles in folding. FP2(arm) bears a negative charge cluster suggesting an exo-site for hemoglobin binding.","method":"X-ray crystallography (crystal structure with cystatin); site-directed mutagenesis; functional activity assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with mutagenesis validation, multiple orthogonal methods in one study","pmids":["16864794"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"Crystal structure of FP2A at 2.9 Å bound to the covalent inhibitor E-64 reveals that relative shape and flexibility of the S2 pocket are influenced by discrete amino acid substitutions, explaining kinetic differences between FP2A and falcipain-3. This represents the first crystal structure of a plasmodial cysteine protease with a small molecule inhibitor.","method":"X-ray crystallography (2.9 Å, FP2A-E64 complex); structural comparison with falcipain-3-leupeptin complex","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure at defined resolution with structural analysis of active site","pmids":["19128015"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"finding":"FP2A folding does not require its prodomain; instead, a 17-amino acid N-terminal segment of the mature protease acts as a chaperone-like peptide required for correct folding. The prodomain functions as a potent, competitive, and reversible inhibitor of mature FP2A (Ki ~10^-10 M) rather than as a folding chaperone.","method":"Recombinant expression of multiple pro- and mature domain constructs in E. coli; refolding assays; in trans complementation with isolated peptide; kinetic inhibition assays (Ki determination)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution of folding in vitro with mutagenesis/deletion constructs and quantitative inhibition kinetics","pmids":["11827964"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2005,"finding":"FP2A is synthesized through the trophozoite stage, is localized to the food vacuole (confirmed by immunofluorescence and immunoelectron microscopy), is synthesized as a membrane-bound proform that is processed to a soluble mature form more quickly than falcipain-3, and its autocatalytic processing occurs in a specific cellular compartment before delivery to the food vacuole (lipophilic but not hydrophilic cysteine protease inhibitors block processing, while both block hemoglobinase activity).","method":"Metabolic labeling and immunoprecipitation; immunofluorescence microscopy; immunoelectron microscopy; subcellular fractionation; inhibitor studies with E-64, E-64d, leupeptin, brefeldin A","journal":"Molecular and biochemical parasitology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal localization and processing methods (IEM, fractionation, metabolic labeling, inhibitor panel) in a single study","pmids":["15664655"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2007,"finding":"FP2A is trafficked to the food vacuole via a classical vesicle-mediated secretory pathway involving the endoplasmic reticulum and Golgi-like apparatus, carried in cytostomal vesicles; the N-terminal sequence (residues 1–120) is sufficient for food vacuole targeting.","method":"Transgenic parasites expressing falcipain-2-GFP chimeras; FRAP (photobleaching); confocal microscopy; anti-falcipain-2 antibody immunolocalization","journal":"Molecular and biochemical parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live imaging with GFP fusions and FRAP in transgenic parasites, single lab","pmids":["17698213"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2007,"finding":"FP2A requires a bipartite motif in its prodomain for food vacuole trafficking: both a 20-amino acid stretch of the lumenal portion and a 10-amino acid stretch of the cytoplasmic portion are required for efficient trafficking; mutants with altered trafficking are arrested at the plasma membrane.","method":"GFP chimeras with serial truncations, deletions, and point mutations in transgenic P. falciparum; fluorescence microscopy","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic mutagenesis with GFP-fusion trafficking readout in transgenic parasites, single lab","pmids":["17565983"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2001,"finding":"Recombinant FP2A cleaves erythrocyte membrane skeletal proteins ankyrin and protein 4.1 in vitro.","method":"In vitro cleavage assay with recombinant FP2A against purified erythrocyte membrane proteins","journal":"Molecular and biochemical parasitology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro enzymatic assay, single study, no in-parasite confirmation described in abstract","pmids":["11463472"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"finding":"FP2A is a target of falstatin, an endogenous P. falciparum cysteine protease inhibitor; recombinant falstatin potently and reversibly inhibits FP2A activity, and antibodies blocking falstatin's inhibitory activity against native and recombinant FP2A dose-dependently decreased erythrocyte invasion by merozoites.","method":"Recombinant expression of falstatin in E. coli; enzyme inhibition assays against FP2A; antibody blocking assays; erythrocyte invasion assays","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical inhibition assay combined with functional invasion assay using blocking antibodies, single lab","pmids":["17083274"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"finding":"FP2A is a component of an ~200-kDa protein complex in the food vacuole required for hemoglobin degradation and hemozoin formation; in vitro, FP2A and heme detoxification protein associate with each other to efficiently convert hemoglobin to hemozoin.","method":"Co-immunoprecipitation followed by mass spectrometry; gel filtration co-elution; glycerol gradient co-sedimentation; in vitro protein interaction assays; in vitro hemoglobin-to-hemozoin conversion assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical methods (Co-IP/MS, gel filtration, glycerol gradient, in vitro reconstitution) from a single rigorous study","pmids":["23471987"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"FP2A shows strong substrate preference for leucine at the P2 position when cleaving peptide substrates, and cleaves hemoglobin at multiple sites across alpha and beta globin chains without a highly ordered pattern, indicating a principal but non-sequential role in hemoglobin hydrolysis.","method":"Random P1–P4 amino acid substrate libraries (positional scanning); overlapping peptide hydrolysis with proteolysis-dependent 18O labeling; intact hemoglobin digestion with product identification by MS","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — three orthogonal substrate specificity methods including mass spectrometry-based cleavage site mapping","pmids":["19357776"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"finding":"The C-terminal inhibitory domain of P. berghei ICP (PbICP-C) forms a 1:1 complex with FP2A, establishing FP2A as a target of ICP-class inhibitors (I42/chagasin-like family); the crystal structure at 2.6 Å reveals that ICP uses a distinct binding mode compared to other chagasin-like inhibitors.","method":"X-ray crystallography (2.6 Å, PbICP-C:FP2A complex)","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure of inhibitor complex with FP2A at defined resolution","pmids":["21742259"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2012,"finding":"Auto-activation of FP2A requires specific salt bridges (Arg185–Glu221 and Glu210–Lys403) and hydrophobic interactions (Phe214, Trp449, Trp453) between its prodomain and mature domain; mutagenesis of these residues abolishes autoprocessing.","method":"Recombinant expression of wild-type and mutant FP2A in E. coli; circular dichroism; trans-activation assays; mutagenesis of salt bridge and hydrophobic residues","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with CD and trans-activation assays, single lab","pmids":["23077573"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2015,"finding":"Heme binds to FP2A with 1:1 stoichiometry and inhibits FP2A activity against both hemoglobin and peptide substrates through a noncompetitive-like mechanism (substrate inhibition induced by heme); a novel inducible heme-binding site adjacent to the catalytic site was identified by docking and molecular dynamics; inhibition requires both propionic and vinyl groups of the heme porphyrin, with minor contribution from iron.","method":"Enzyme kinetic assays; porphyrin analogue structure-activity relationship screen; docking and molecular dynamics simulation","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — kinetic assays with SAR panel and computational identification of binding site, single lab","pmids":["25791019"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2004,"finding":"Site-directed mutagenesis of FP2A identified active-site catalytic triad residues C42, H174, and N204 as essential for catalysis; substitutions at C99 and C119 caused structural alterations with >97% reduction in enzyme activity; S149 is required for specific peptide substrate interactions.","method":"Site-directed mutagenesis (nine mutants); recombinant expression in E. coli; affinity purification; enzymatic activity assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis with quantitative activity assays, single lab","pmids":["15369788"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"finding":"FP2A (PF3D7_1115700) is required for potent artemisinin activity; haplotypes bearing naturally occurring FP2A polymorphisms from Southeast Asia showed increased ring survival and significantly reduced FP2A enzymatic activity compared to wild-type, with haplotype group I showing the slowest protease kinetics and reduced parasite fitness.","method":"Full-length gene sequencing of 140 P. falciparum isolates; functional haplotype analysis; enzymatic activity assays; ring-stage survival assays","journal":"The Journal of infectious diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional activity assays and survival assays on clinical isolate-derived haplotypes, single lab","pmids":["29659945"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2023,"finding":"FP2A interacts with PTEX core components (including PTEX150) and this interaction is required for efficient trafficking of FP2A to the food vacuole; PTEX150 knockdown substantially perturbs hemoglobin digestion, suggesting FP2A is translocated into the parasitophorous vacuole via PTEX to reach the cytostome prior to food vacuole entry.","method":"Conditional knockdown of PTEX150; transgenic parasite lines with GFP fusions; co-immunoprecipitation; hemoglobin digestion assays","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KD with defined phenotype plus Co-IP evidence, single lab","pmids":["37523385"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2019,"finding":"Crystal structure of FP2A at 3.45 Å in complex with an (E)-chalcone small-molecule inhibitor reveals that the inhibitor binds to the rear of the substrate-binding cleft, identifying a novel small-molecule binding site distinct from the active site.","method":"X-ray crystallography (3.45 Å, FP2A-(E)-chalcone complex); structural comparison with previous FP2A complexes","journal":"Malaria journal","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — crystal structure at moderate resolution, single study, limited functional validation described in abstract","pmids":["31791339"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2021,"finding":"Crystal structure of FP2A from the drug-resistant P. falciparum 3D7 strain (with variants R12K, E14N, P100T, G102D in the mature domain) resolved at 3.5 Å (E-64 complex) and 3.4 Å (iodoacetamide complex) reveals two solvent-exposed pockets including one structurally homologous to the allosteric binding site of human cathepsin K, and shows strain-specific multiple binding modes for E-64.","method":"X-ray crystallography (3.5 Å and 3.4 Å with two inhibitors); structural analysis; docking and normal mode analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — crystal structures at moderate resolution with computational follow-up, single study, limited functional validation in abstract","pmids":["34974303"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"}]}],"current_model":"FP2A (PF3D7_1115700) is a papain-family cysteine protease that is synthesized as a membrane-bound zymogen in trophozoites, undergoes autocatalytic processing (mediated by specific salt bridges and hydrophobic prodomain–mature domain interactions) in a pre-food vacuole compartment, and is trafficked to the food vacuole via a PTEX-dependent, bipartite-motif-directed vesicular secretory pathway, where it functions as the principal hemoglobinase (responsible for >93% of trophozoite cysteine protease activity); hemoglobin capture is mediated by a unique C-terminal beta-hairpin exo-site (FP2(arm)) independent of the active site, the enzyme preferentially cleaves hemoglobin at sites with Leu at P2, and its activity is allosterically inhibited by heme and regulated by the endogenous inhibitor falstatin; FP2A also participates in an ~200 kDa food vacuole complex with plasmepsins and heme detoxification protein that couples hemoglobin degradation to hemozoin formation, and reduced FP2A activity is associated with decreased artemisinin sensitivity."},"narrative":{"mechanistic_narrative":"FP2A (PF3D7_1115700) is the principal trophozoite-stage cysteine protease of Plasmodium falciparum, accounting for at least 93% of soluble trophozoite cysteine protease activity and functioning as the major hemoglobinase during intraerythrocytic development [PMID:10887194]. Genetic disruption produces trophozoites with swollen, hemoglobin-filled food vacuoles and heightened sensitivity to both cysteine and aspartic protease inhibitors, establishing FP2A's central and cooperative role in hemoglobin catabolism [PMID:15070727, PMID:16890302]. Catalysis depends on an active-site triad (C42, H174, N204), while hemoglobin engagement is directed by a unique C-terminal beta-hairpin exo-site (FP2(arm)) that binds hemoglobin independently of the active site—deletion abolishes hemoglobinase activity without affecting peptide substrate cleavage [PMID:15964982, PMID:15369788]; a second structural element, FP2(nose), is required for folding [PMID:16864794]. The enzyme cleaves hemoglobin at multiple sites with a strong preference for leucine at P2 [PMID:19357776]. FP2A is synthesized as a membrane-bound zymogen that folds without its prodomain (which instead acts as a potent reversible inhibitor) and undergoes autocatalytic processing governed by defined prodomain–mature-domain salt bridges and hydrophobic contacts before delivery to the food vacuole [PMID:11827964, PMID:23077573]; trafficking proceeds through a vesicular secretory route directed by a bipartite prodomain motif and requires interaction with PTEX components [PMID:17698213, PMID:17565983, PMID:37523385]. Within the food vacuole FP2A assembles into an ~200-kDa complex with heme detoxification protein and plasmepsins that couples hemoglobin degradation to hemozoin formation [PMID:23471987]. FP2A activity is constrained by the endogenous inhibitors falstatin and ICP and is allosterically inhibited by heme [PMID:17083274, PMID:21742259, PMID:25791019]. Reduced FP2A enzymatic activity, associated with naturally occurring Southeast Asian polymorphisms, is linked to decreased artemisinin sensitivity [PMID:29659945].","teleology":[{"year":2000,"claim":"Established that FP2A is the dominant trophozoite cysteine protease and a hemoglobinase, defining its core biological role in the intraerythrocytic parasite.","evidence":"Native enzyme purification plus recombinant refolding, activity assays against hemoglobin/globin, and immunolocalization in P. falciparum","pmids":["10887194"],"confidence":"High","gaps":["Relative contribution versus other food-vacuole proteases not resolved by biochemistry alone","In vivo essentiality not addressed at this stage"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"claim":"Resolved the folding logic of the enzyme by showing the prodomain is not a folding chaperone but a high-affinity reversible inhibitor, while an N-terminal mature-domain segment enables folding.","evidence":"Recombinant pro/mature constructs, in trans peptide complementation, and Ki determination in E. coli-expressed protein","pmids":["11827964"],"confidence":"High","gaps":["Physiological timing of prodomain release in vivo not defined","How inhibition is relieved during activation unclear"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2004,"claim":"Genetic disruption confirmed FP2A's specific in-parasite role in hemoglobin degradation and revealed cooperative action with aspartic proteases.","evidence":"Gene knockout by homologous recombination with morphology, activity, and inhibitor sensitivity assays; catalytic triad defined by mutagenesis","pmids":["15070727","15369788"],"confidence":"High","gaps":["Residual hemoglobin digestion in KO indicates redundancy whose molecular basis is unspecified","Non-hemoglobin roles not tested"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2005,"claim":"Identified the FP2(arm) exo-site as the determinant of hemoglobinase activity, separating hemoglobin capture from the catalytic active site, and mapped trafficking and processing to a pre-food-vacuole compartment.","evidence":"Deletion mutagenesis with substrate/binding assays; metabolic labeling, immunoEM, fractionation, and inhibitor panel in P. falciparum","pmids":["15964982","15664655"],"confidence":"High","gaps":["Structural basis of exo-site hemoglobin recognition not yet visualized","Identity of the processing compartment not molecularly defined"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"claim":"Structural determination of mature FP2A and its cystatin complex revealed the FP2(arm) and FP2(nose) motifs and demonstrated pH-dependent hemoglobin binding and trans-processing, providing an atomic framework for substrate capture and folding.","evidence":"X-ray crystallography (3.1 Å free, 2.9 Å cystatin complex) with mutagenesis and pH-dependent binding assays; independent KO replication in 3D7","pmids":["16777845","16864794","16890302"],"confidence":"High","gaps":["Structure of an FP2A–hemoglobin complex still lacking","Dynamics linking pH to exo-site engagement inferred, not directly captured"],"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"}]},{"year":2006,"claim":"Identified falstatin as an endogenous inhibitor of FP2A and linked its regulation to merozoite invasion, extending FP2A's relevance beyond food-vacuole hemoglobin digestion.","evidence":"Recombinant falstatin inhibition assays and antibody-blocking erythrocyte invasion assays","pmids":["17083274"],"confidence":"Medium","gaps":["Direct in-parasite demonstration of FP2A action during invasion not shown","Single-lab functional linkage"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2007,"claim":"Defined the secretory trafficking route and a bipartite prodomain trafficking signal directing FP2A to the food vacuole.","evidence":"GFP chimeras, serial truncation/point mutants, FRAP, and confocal imaging in transgenic P. falciparum","pmids":["17698213","17565983"],"confidence":"Medium","gaps":["Trafficking receptors recognizing the bipartite motif unidentified","Single-lab GFP-fusion evidence"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"Mapped substrate specificity (P2 leucine preference, distributed hemoglobin cleavage) and the active-site plasticity distinguishing FP2A from falcipain-3, informing inhibitor design.","evidence":"Positional-scanning libraries, 18O-labeling cleavage mapping, MS-based hemoglobin digestion, and E-64 co-crystal structure","pmids":["19357776","19128015"],"confidence":"High","gaps":["Physiological ordering of hemoglobin cleavage in vivo not established","Contribution of exo-site to cleavage-site selection not deconvolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"claim":"Extended the inhibitor repertoire by resolving an ICP (chagasin-like) inhibitor bound to FP2A, revealing a distinct binding mode.","evidence":"X-ray crystallography of PbICP-C:FP2A complex at 2.6 Å","pmids":["21742259"],"confidence":"High","gaps":["Physiological role of ICP–FP2A regulation in vivo not addressed","Inhibitor is a P. berghei protein bound to P. falciparum FP2A"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2012,"claim":"Defined the molecular determinants of autoactivation, showing specific salt bridges and hydrophobic prodomain–mature-domain contacts are required for autoprocessing.","evidence":"Mutagenesis, circular dichroism, and trans-activation assays on recombinant FP2A","pmids":["23077573"],"confidence":"Medium","gaps":["In vivo requirement of these residues not tested","Single-lab in vitro system"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"claim":"Placed FP2A within an ~200-kDa food-vacuole complex coupling hemoglobin degradation to hemozoin formation, integrating proteolysis with heme detoxification.","evidence":"Co-IP/MS, gel filtration, glycerol gradient co-sedimentation, and in vitro hemoglobin-to-hemozoin reconstitution","pmids":["23471987"],"confidence":"High","gaps":["Stoichiometry and spatial organization of the complex undefined","Whether complex assembly is required for activity in vivo unclear"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2015,"claim":"Identified heme as an allosteric inhibitor of FP2A via an inducible binding site, suggesting product feedback regulation of hemoglobin digestion.","evidence":"Enzyme kinetics, porphyrin analogue SAR, and docking/molecular dynamics","pmids":["25791019"],"confidence":"Medium","gaps":["Binding site identified computationally, not crystallographically","Physiological significance of the feedback not demonstrated in parasites"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"claim":"Linked reduced FP2A enzymatic activity from natural polymorphisms to increased ring-stage survival, connecting FP2A function to artemisinin sensitivity.","evidence":"Full-length sequencing of 140 isolates, haplotype-based activity assays, and ring-stage survival assays","pmids":["29659945"],"confidence":"Medium","gaps":["Mechanistic link between hemoglobin digestion and artemisinin activation not directly demonstrated","Single-lab functional haplotype analysis"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2023,"claim":"Revealed a PTEX-dependent step in FP2A trafficking, indicating translocation into the parasitophorous vacuole en route to the food vacuole.","evidence":"Conditional PTEX150 knockdown, GFP-fusion lines, Co-IP, and hemoglobin digestion assays","pmids":["37523385"],"confidence":"Medium","gaps":["Direct mechanism of FP2A passage through PTEX unresolved","Single-lab conditional knockdown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"The precise coupling between FP2A hemoglobin catabolism, heme handling within the ~200-kDa complex, and artemisinin activation remains mechanistically unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of FP2A bound to hemoglobin or within the food-vacuole complex","In-parasite necessity of autoactivation residues and heme-feedback site untested","Molecular mechanism of PTEX-mediated FP2A translocation unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["~200-kDa food-vacuole hemoglobin-degradation complex containing FP2A, heme detoxification protein, and plasmepsins [#13]","FP2A:falstatin inhibitory complex [#12]","FP2A:PbICP-C (chagasin-like inhibitor) complex [#15]","FP2A:cystatin complex [#5]"],"partners":["HEME DETOXIFICATION PROTEIN (HDP) [#13]","FALSTATIN (ENDOGENOUS CYSTEINE PROTEASE INHIBITOR) [#12]","ICP / PBICP-C (CHAGASIN-LIKE INHIBITOR) [#15]","PTEX COMPONENTS INCLUDING PTEX150 [#20]"],"other_free_text":["Active-site catalytic triad C42, H174, N204; C99/C119 structurally important; S149 for peptide substrate interaction [#18]","C-terminal beta-hairpin exo-site FP2(arm) mediates active-site-independent hemoglobin binding; deletion abolishes hemoglobinase activity [#3, #5]","N-terminal FP2(nose) motif required for prodomain-independent folding [#5]","Prodomain is a potent reversible competitive inhibitor (Ki ~10^-10 M), not a folding chaperone [#7]","Autoactivation requires salt bridges Arg185-Glu221 and Glu210-Lys403 and hydrophobic residues Phe214, Trp449, Trp453 [#16]","Synthesized as a membrane-bound zymogen; autocatalytic processing precedes food-vacuole delivery; bipartite prodomain trafficking motif [#8, #10]","Strong P2 leucine substrate preference; distributed hemoglobin cleavage [#14]","Heme binds 1:1 and allosterically inhibits activity via an inducible site adjacent to the catalytic center [#17]","Reduced FP2A activity from Southeast Asian polymorphisms associated with increased ring survival / decreased artemisinin sensitivity [#19]","Small-molecule inhibitor structures reveal active-site (E-64) and non-active-site binding pockets, including a cathepsin K-like allosteric site [#6, #21, #22]","In vitro cleaves erythrocyte membrane skeletal proteins ankyrin and protein 4.1 [#11]"]}},"prefetch_data":{},"corpus_meta":[{"pmid":"10887194","id":"PMC_10887194","title":"Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10887194","citation_count":292,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15070727","id":"PMC_15070727","title":"Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15070727","citation_count":245,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23471987","id":"PMC_23471987","title":"Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23471987","citation_count":131,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19128015","id":"PMC_19128015","title":"Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity.","date":"2009","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19128015","citation_count":127,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16890302","id":"PMC_16890302","title":"Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum.","date":"2006","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/16890302","citation_count":125,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15964982","id":"PMC_15964982","title":"The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15964982","citation_count":113,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25144768","id":"PMC_25144768","title":"Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25144768","citation_count":103,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16777845","id":"PMC_16777845","title":"Structural and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16777845","citation_count":102,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16864794","id":"PMC_16864794","title":"Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16864794","citation_count":86,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11463472","id":"PMC_11463472","title":"Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1.","date":"2001","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11463472","citation_count":75,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17083274","id":"PMC_17083274","title":"Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion.","date":"2006","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/17083274","citation_count":72,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15664655","id":"PMC_15664655","title":"Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum.","date":"2005","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/15664655","citation_count":67,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16722625","id":"PMC_16722625","title":"Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents.","date":"2006","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16722625","citation_count":57,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["FP2A"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19357776","id":"PMC_19357776","title":"Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19357776","citation_count":55,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11827964","id":"PMC_11827964","title":"Folding of the Plasmodium falciparum cysteine protease falcipain-2 is mediated by a chaperone-like peptide and not the prodomain.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11827964","citation_count":50,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17565983","id":"PMC_17565983","title":"Falcipain cysteine proteases require bipartite motifs for trafficking to the Plasmodium falciparum food vacuole.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17565983","citation_count":40,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21742259","id":"PMC_21742259","title":"Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium.","date":"2011","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/21742259","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29659945","id":"PMC_29659945","title":"Plasmodium falciparum Falcipain-2a Polymorphisms in Southeast Asia and Their Association With Artemisinin Resistance.","date":"2018","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29659945","citation_count":30,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["FP2A"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17698213","id":"PMC_17698213","title":"Food vacuole targeting and trafficking of falcipain-2, an important cysteine protease of human malaria parasite Plasmodium falciparum.","date":"2007","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/17698213","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31791339","id":"PMC_31791339","title":"The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site.","date":"2019","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/31791339","citation_count":22,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15369788","id":"PMC_15369788","title":"Homology modeling and mutagenesis analyses of Plasmodium falciparum falcipain 2A: implications for rational drug design.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15369788","citation_count":15,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["FP2A"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23077573","id":"PMC_23077573","title":"The Ionic and hydrophobic interactions are required for the auto activation of cysteine proteases of Plasmodium falciparum.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23077573","citation_count":15,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25791019","id":"PMC_25791019","title":"Allosteric regulation of the Plasmodium falciparum cysteine protease falcipain-2 by heme.","date":"2015","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/25791019","citation_count":12,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16095562","id":"PMC_16095562","title":"Characterization of amino acid variation at strategic positions in parasite and human proteases for selective inhibition of falcipains in Plasmodium falciparum.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16095562","citation_count":10,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["FP2A"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31247344","id":"PMC_31247344","title":"Inhibition of Plasmodium falciparum cysteine protease falcipain-2 by a human cross-class inhibitor serpinB3: A mechanistic insight.","date":"2019","source":"Biochimica et biophysica acta. Proteins and proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/31247344","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"37523385","id":"PMC_37523385","title":"PTEX helps efficiently traffic haemoglobinases to the food vacuole in Plasmodium falciparum.","date":"2023","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/37523385","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"34974303","id":"PMC_34974303","title":"New insights of falcipain 2 structure from Plasmodium falciparum 3D7 strain.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/34974303","citation_count":5,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24943200","id":"PMC_24943200","title":"Dynamical footprint of falcipain-2 catalytic triad in hemoglobin-β-bound state.","date":"2014","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/24943200","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"41245893","id":"PMC_41245893","title":"Decoding substrate recognition in malapain-2 through structural and mutational insights.","date":"2025","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/41245893","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["FP2A"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16791,"output_tokens":6426,"usd":0.073382,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13709,"output_tokens":5770,"usd":0.106398,"stage2_stop_reason":"end_turn"},"total_usd":0.17978,"stage1_batch_id":"msgbatch_01DisAaTypwmC8QwdMBuePHo","stage2_batch_id":"msgbatch_0184zxZTqxiEfdYYfPMfkqjb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"FP2A (falcipain-2) is the principal trophozoite cysteine protease of P. falciparum, responsible for at least 93% of trophozoite soluble cysteine protease activity; it is concentrated in food vacuoles, hydrolyzes both native hemoglobin and denatured globin optimally at acid pH in a reducing environment, and can initiate cleavage of native hemoglobin.\",\n      \"method\": \"Affinity chromatography purification of native enzyme; recombinant expression in E. coli with refolding; enzymatic assays against peptide substrates, native hemoglobin, and denatured globin; immunolocalization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — purification of native enzyme plus recombinant reconstitution, multiple orthogonal methods (activity assay, localization, substrate assay), replicated by subsequent studies\",\n      \"pmids\": [\"10887194\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Genetic disruption of the FP2A gene in P. falciparum causes markedly diminished trophozoite cysteine protease activity and swollen, hemoglobin-filled food vacuoles, confirming FP2A's specific role in hemoglobin hydrolysis during the trophozoite stage; knockout parasites showed increased sensitivity to cysteine and aspartic protease inhibitors, revealing cooperative action between cysteine and aspartic proteases in hemoglobin degradation.\",\n      \"method\": \"Gene disruption (knockout) by homologous recombination; morphological analysis; cysteine protease activity assay; drug sensitivity assays (E-64, leupeptin, pepstatin)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple orthogonal readouts, replicated in a subsequent study (PMID:16890302)\",\n      \"pmids\": [\"15070727\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Disruption of the FP2A gene in the 3D7 strain produced swollen hemoglobin-filled food vacuoles in trophozoites; FP2A knockout parasites were twice as sensitive to cysteine protease inhibitors and over 1000-fold more sensitive to an aspartic protease inhibitor compared to wild-type, further supporting FP2A's role in hemoglobin hydrolysis and the cooperative interplay between cysteine and aspartic proteases.\",\n      \"method\": \"Gene disruption in 3D7 strain; morphological analysis; drug sensitivity assays\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — independent replication of KO phenotype in defined strain with quantitative drug sensitivity readouts\",\n      \"pmids\": [\"16890302\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}]\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"FP2A possesses a unique 14-amino acid C-terminal beta-hairpin motif (FP2(arm)) that mediates binding to hemoglobin independent of the active site; deletion of 10 residues of this motif abolishes activity against hemoglobin and globin but not against peptide substrates, casein, or gelatin. This motif also mediates interaction with the prodomain inhibitor of FP2A.\",\n      \"method\": \"Site-directed mutagenesis (deletion mutant Delta10FP2A); enzymatic assays against peptide substrates, hemoglobin, globin, casein, gelatin; E-64-inhibited complex pulldown to assess hemoglobin binding; peptide competition assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — active-site independent binding demonstrated by mutagenesis plus multiple substrate/binding assays in a single rigorous study\",\n      \"pmids\": [\"15964982\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Crystal structure of mature FP2A at 3.1 Å resolution reveals a dynamic beta-hairpin hemoglobin-binding motif (FP2(arm)), a flexible N-terminal alpha-helical extension, and a unique active-site cleft. Biochemical assays showed that mature FP2A can proteolytically process its own precursor in trans at neutral to weakly alkaline pH, that hemoglobin binding is strictly pH-dependent, and that FP2A preferentially binds methemoglobin over hemoglobin.\",\n      \"method\": \"X-ray crystallography (3.1 Å); biochemical processing assays; hemoglobin-binding assays under varying pH conditions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure combined with functional biochemical assays in a single study\",\n      \"pmids\": [\"16777845\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Crystal structure of FP2A in complex with the protease inhibitor cystatin at 2.9 Å reveals two unique structural motifs: FP2(nose), a short N-terminal segment required for folding without a prodomain, and FP2(arm), required for hemoglobinase activity. Mutagenesis of two Tyr within FP2(nose) and a conserved Glu outside it confirmed their functional roles in folding. FP2(arm) bears a negative charge cluster suggesting an exo-site for hemoglobin binding.\",\n      \"method\": \"X-ray crystallography (crystal structure with cystatin); site-directed mutagenesis; functional activity assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with mutagenesis validation, multiple orthogonal methods in one study\",\n      \"pmids\": [\"16864794\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of FP2A at 2.9 Å bound to the covalent inhibitor E-64 reveals that relative shape and flexibility of the S2 pocket are influenced by discrete amino acid substitutions, explaining kinetic differences between FP2A and falcipain-3. This represents the first crystal structure of a plasmodial cysteine protease with a small molecule inhibitor.\",\n      \"method\": \"X-ray crystallography (2.9 Å, FP2A-E64 complex); structural comparison with falcipain-3-leupeptin complex\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure at defined resolution with structural analysis of active site\",\n      \"pmids\": [\"19128015\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FP2A folding does not require its prodomain; instead, a 17-amino acid N-terminal segment of the mature protease acts as a chaperone-like peptide required for correct folding. The prodomain functions as a potent, competitive, and reversible inhibitor of mature FP2A (Ki ~10^-10 M) rather than as a folding chaperone.\",\n      \"method\": \"Recombinant expression of multiple pro- and mature domain constructs in E. coli; refolding assays; in trans complementation with isolated peptide; kinetic inhibition assays (Ki determination)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution of folding in vitro with mutagenesis/deletion constructs and quantitative inhibition kinetics\",\n      \"pmids\": [\"11827964\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"FP2A is synthesized through the trophozoite stage, is localized to the food vacuole (confirmed by immunofluorescence and immunoelectron microscopy), is synthesized as a membrane-bound proform that is processed to a soluble mature form more quickly than falcipain-3, and its autocatalytic processing occurs in a specific cellular compartment before delivery to the food vacuole (lipophilic but not hydrophilic cysteine protease inhibitors block processing, while both block hemoglobinase activity).\",\n      \"method\": \"Metabolic labeling and immunoprecipitation; immunofluorescence microscopy; immunoelectron microscopy; subcellular fractionation; inhibitor studies with E-64, E-64d, leupeptin, brefeldin A\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal localization and processing methods (IEM, fractionation, metabolic labeling, inhibitor panel) in a single study\",\n      \"pmids\": [\"15664655\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"FP2A is trafficked to the food vacuole via a classical vesicle-mediated secretory pathway involving the endoplasmic reticulum and Golgi-like apparatus, carried in cytostomal vesicles; the N-terminal sequence (residues 1–120) is sufficient for food vacuole targeting.\",\n      \"method\": \"Transgenic parasites expressing falcipain-2-GFP chimeras; FRAP (photobleaching); confocal microscopy; anti-falcipain-2 antibody immunolocalization\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging with GFP fusions and FRAP in transgenic parasites, single lab\",\n      \"pmids\": [\"17698213\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"FP2A requires a bipartite motif in its prodomain for food vacuole trafficking: both a 20-amino acid stretch of the lumenal portion and a 10-amino acid stretch of the cytoplasmic portion are required for efficient trafficking; mutants with altered trafficking are arrested at the plasma membrane.\",\n      \"method\": \"GFP chimeras with serial truncations, deletions, and point mutations in transgenic P. falciparum; fluorescence microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic mutagenesis with GFP-fusion trafficking readout in transgenic parasites, single lab\",\n      \"pmids\": [\"17565983\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Recombinant FP2A cleaves erythrocyte membrane skeletal proteins ankyrin and protein 4.1 in vitro.\",\n      \"method\": \"In vitro cleavage assay with recombinant FP2A against purified erythrocyte membrane proteins\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro enzymatic assay, single study, no in-parasite confirmation described in abstract\",\n      \"pmids\": [\"11463472\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FP2A is a target of falstatin, an endogenous P. falciparum cysteine protease inhibitor; recombinant falstatin potently and reversibly inhibits FP2A activity, and antibodies blocking falstatin's inhibitory activity against native and recombinant FP2A dose-dependently decreased erythrocyte invasion by merozoites.\",\n      \"method\": \"Recombinant expression of falstatin in E. coli; enzyme inhibition assays against FP2A; antibody blocking assays; erythrocyte invasion assays\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical inhibition assay combined with functional invasion assay using blocking antibodies, single lab\",\n      \"pmids\": [\"17083274\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"FP2A is a component of an ~200-kDa protein complex in the food vacuole required for hemoglobin degradation and hemozoin formation; in vitro, FP2A and heme detoxification protein associate with each other to efficiently convert hemoglobin to hemozoin.\",\n      \"method\": \"Co-immunoprecipitation followed by mass spectrometry; gel filtration co-elution; glycerol gradient co-sedimentation; in vitro protein interaction assays; in vitro hemoglobin-to-hemozoin conversion assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical methods (Co-IP/MS, gel filtration, glycerol gradient, in vitro reconstitution) from a single rigorous study\",\n      \"pmids\": [\"23471987\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"FP2A shows strong substrate preference for leucine at the P2 position when cleaving peptide substrates, and cleaves hemoglobin at multiple sites across alpha and beta globin chains without a highly ordered pattern, indicating a principal but non-sequential role in hemoglobin hydrolysis.\",\n      \"method\": \"Random P1–P4 amino acid substrate libraries (positional scanning); overlapping peptide hydrolysis with proteolysis-dependent 18O labeling; intact hemoglobin digestion with product identification by MS\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — three orthogonal substrate specificity methods including mass spectrometry-based cleavage site mapping\",\n      \"pmids\": [\"19357776\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The C-terminal inhibitory domain of P. berghei ICP (PbICP-C) forms a 1:1 complex with FP2A, establishing FP2A as a target of ICP-class inhibitors (I42/chagasin-like family); the crystal structure at 2.6 Å reveals that ICP uses a distinct binding mode compared to other chagasin-like inhibitors.\",\n      \"method\": \"X-ray crystallography (2.6 Å, PbICP-C:FP2A complex)\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure of inhibitor complex with FP2A at defined resolution\",\n      \"pmids\": [\"21742259\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Auto-activation of FP2A requires specific salt bridges (Arg185–Glu221 and Glu210–Lys403) and hydrophobic interactions (Phe214, Trp449, Trp453) between its prodomain and mature domain; mutagenesis of these residues abolishes autoprocessing.\",\n      \"method\": \"Recombinant expression of wild-type and mutant FP2A in E. coli; circular dichroism; trans-activation assays; mutagenesis of salt bridge and hydrophobic residues\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with CD and trans-activation assays, single lab\",\n      \"pmids\": [\"23077573\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Heme binds to FP2A with 1:1 stoichiometry and inhibits FP2A activity against both hemoglobin and peptide substrates through a noncompetitive-like mechanism (substrate inhibition induced by heme); a novel inducible heme-binding site adjacent to the catalytic site was identified by docking and molecular dynamics; inhibition requires both propionic and vinyl groups of the heme porphyrin, with minor contribution from iron.\",\n      \"method\": \"Enzyme kinetic assays; porphyrin analogue structure-activity relationship screen; docking and molecular dynamics simulation\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — kinetic assays with SAR panel and computational identification of binding site, single lab\",\n      \"pmids\": [\"25791019\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Site-directed mutagenesis of FP2A identified active-site catalytic triad residues C42, H174, and N204 as essential for catalysis; substitutions at C99 and C119 caused structural alterations with >97% reduction in enzyme activity; S149 is required for specific peptide substrate interactions.\",\n      \"method\": \"Site-directed mutagenesis (nine mutants); recombinant expression in E. coli; affinity purification; enzymatic activity assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis with quantitative activity assays, single lab\",\n      \"pmids\": [\"15369788\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FP2A (PF3D7_1115700) is required for potent artemisinin activity; haplotypes bearing naturally occurring FP2A polymorphisms from Southeast Asia showed increased ring survival and significantly reduced FP2A enzymatic activity compared to wild-type, with haplotype group I showing the slowest protease kinetics and reduced parasite fitness.\",\n      \"method\": \"Full-length gene sequencing of 140 P. falciparum isolates; functional haplotype analysis; enzymatic activity assays; ring-stage survival assays\",\n      \"journal\": \"The Journal of infectious diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional activity assays and survival assays on clinical isolate-derived haplotypes, single lab\",\n      \"pmids\": [\"29659945\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FP2A interacts with PTEX core components (including PTEX150) and this interaction is required for efficient trafficking of FP2A to the food vacuole; PTEX150 knockdown substantially perturbs hemoglobin digestion, suggesting FP2A is translocated into the parasitophorous vacuole via PTEX to reach the cytostome prior to food vacuole entry.\",\n      \"method\": \"Conditional knockdown of PTEX150; transgenic parasite lines with GFP fusions; co-immunoprecipitation; hemoglobin digestion assays\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KD with defined phenotype plus Co-IP evidence, single lab\",\n      \"pmids\": [\"37523385\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Crystal structure of FP2A at 3.45 Å in complex with an (E)-chalcone small-molecule inhibitor reveals that the inhibitor binds to the rear of the substrate-binding cleft, identifying a novel small-molecule binding site distinct from the active site.\",\n      \"method\": \"X-ray crystallography (3.45 Å, FP2A-(E)-chalcone complex); structural comparison with previous FP2A complexes\",\n      \"journal\": \"Malaria journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structure at moderate resolution, single study, limited functional validation described in abstract\",\n      \"pmids\": [\"31791339\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Crystal structure of FP2A from the drug-resistant P. falciparum 3D7 strain (with variants R12K, E14N, P100T, G102D in the mature domain) resolved at 3.5 Å (E-64 complex) and 3.4 Å (iodoacetamide complex) reveals two solvent-exposed pockets including one structurally homologous to the allosteric binding site of human cathepsin K, and shows strain-specific multiple binding modes for E-64.\",\n      \"method\": \"X-ray crystallography (3.5 Å and 3.4 Å with two inhibitors); structural analysis; docking and normal mode analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structures at moderate resolution with computational follow-up, single study, limited functional validation in abstract\",\n      \"pmids\": [\"34974303\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}]\n    }\n  ],\n  \"current_model\": \"FP2A (PF3D7_1115700) is a papain-family cysteine protease that is synthesized as a membrane-bound zymogen in trophozoites, undergoes autocatalytic processing (mediated by specific salt bridges and hydrophobic prodomain–mature domain interactions) in a pre-food vacuole compartment, and is trafficked to the food vacuole via a PTEX-dependent, bipartite-motif-directed vesicular secretory pathway, where it functions as the principal hemoglobinase (responsible for >93% of trophozoite cysteine protease activity); hemoglobin capture is mediated by a unique C-terminal beta-hairpin exo-site (FP2(arm)) independent of the active site, the enzyme preferentially cleaves hemoglobin at sites with Leu at P2, and its activity is allosterically inhibited by heme and regulated by the endogenous inhibitor falstatin; FP2A also participates in an ~200 kDa food vacuole complex with plasmepsins and heme detoxification protein that couples hemoglobin degradation to hemozoin formation, and reduced FP2A activity is associated with decreased artemisinin sensitivity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"FP2A (PF3D7_1115700) is the principal trophozoite-stage cysteine protease of Plasmodium falciparum, accounting for at least 93% of soluble trophozoite cysteine protease activity and functioning as the major hemoglobinase during intraerythrocytic development [#0]. Genetic disruption produces trophozoites with swollen, hemoglobin-filled food vacuoles and heightened sensitivity to both cysteine and aspartic protease inhibitors, establishing FP2A's central and cooperative role in hemoglobin catabolism [#1, #2]. Catalysis depends on an active-site triad (C42, H174, N204), while hemoglobin engagement is directed by a unique C-terminal beta-hairpin exo-site (FP2(arm)) that binds hemoglobin independently of the active site—deletion abolishes hemoglobinase activity without affecting peptide substrate cleavage [#3, #18]; a second structural element, FP2(nose), is required for folding [#5]. The enzyme cleaves hemoglobin at multiple sites with a strong preference for leucine at P2 [#14]. FP2A is synthesized as a membrane-bound zymogen that folds without its prodomain (which instead acts as a potent reversible inhibitor) and undergoes autocatalytic processing governed by defined prodomain–mature-domain salt bridges and hydrophobic contacts before delivery to the food vacuole [#7, #16]; trafficking proceeds through a vesicular secretory route directed by a bipartite prodomain motif and requires interaction with PTEX components [#9, #10, #20]. Within the food vacuole FP2A assembles into an ~200-kDa complex with heme detoxification protein and plasmepsins that couples hemoglobin degradation to hemozoin formation [#13]. FP2A activity is constrained by the endogenous inhibitors falstatin and ICP and is allosterically inhibited by heme [#12, #15, #17]. Reduced FP2A enzymatic activity, associated with naturally occurring Southeast Asian polymorphisms, is linked to decreased artemisinin sensitivity [#19].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that FP2A is the dominant trophozoite cysteine protease and a hemoglobinase, defining its core biological role in the intraerythrocytic parasite.\",\n      \"evidence\": \"Native enzyme purification plus recombinant refolding, activity assays against hemoglobin/globin, and immunolocalization in P. falciparum\",\n      \"pmids\": [\"10887194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution versus other food-vacuole proteases not resolved by biochemistry alone\", \"In vivo essentiality not addressed at this stage\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolved the folding logic of the enzyme by showing the prodomain is not a folding chaperone but a high-affinity reversible inhibitor, while an N-terminal mature-domain segment enables folding.\",\n      \"evidence\": \"Recombinant pro/mature constructs, in trans peptide complementation, and Ki determination in E. coli-expressed protein\",\n      \"pmids\": [\"11827964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological timing of prodomain release in vivo not defined\", \"How inhibition is relieved during activation unclear\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Genetic disruption confirmed FP2A's specific in-parasite role in hemoglobin degradation and revealed cooperative action with aspartic proteases.\",\n      \"evidence\": \"Gene knockout by homologous recombination with morphology, activity, and inhibitor sensitivity assays; catalytic triad defined by mutagenesis\",\n      \"pmids\": [\"15070727\", \"15369788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Residual hemoglobin digestion in KO indicates redundancy whose molecular basis is unspecified\", \"Non-hemoglobin roles not tested\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified the FP2(arm) exo-site as the determinant of hemoglobinase activity, separating hemoglobin capture from the catalytic active site, and mapped trafficking and processing to a pre-food-vacuole compartment.\",\n      \"evidence\": \"Deletion mutagenesis with substrate/binding assays; metabolic labeling, immunoEM, fractionation, and inhibitor panel in P. falciparum\",\n      \"pmids\": [\"15964982\", \"15664655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of exo-site hemoglobin recognition not yet visualized\", \"Identity of the processing compartment not molecularly defined\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Structural determination of mature FP2A and its cystatin complex revealed the FP2(arm) and FP2(nose) motifs and demonstrated pH-dependent hemoglobin binding and trans-processing, providing an atomic framework for substrate capture and folding.\",\n      \"evidence\": \"X-ray crystallography (3.1 Å free, 2.9 Å cystatin complex) with mutagenesis and pH-dependent binding assays; independent KO replication in 3D7\",\n      \"pmids\": [\"16777845\", \"16864794\", \"16890302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of an FP2A–hemoglobin complex still lacking\", \"Dynamics linking pH to exo-site engagement inferred, not directly captured\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified falstatin as an endogenous inhibitor of FP2A and linked its regulation to merozoite invasion, extending FP2A's relevance beyond food-vacuole hemoglobin digestion.\",\n      \"evidence\": \"Recombinant falstatin inhibition assays and antibody-blocking erythrocyte invasion assays\",\n      \"pmids\": [\"17083274\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct in-parasite demonstration of FP2A action during invasion not shown\", \"Single-lab functional linkage\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined the secretory trafficking route and a bipartite prodomain trafficking signal directing FP2A to the food vacuole.\",\n      \"evidence\": \"GFP chimeras, serial truncation/point mutants, FRAP, and confocal imaging in transgenic P. falciparum\",\n      \"pmids\": [\"17698213\", \"17565983\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trafficking receptors recognizing the bipartite motif unidentified\", \"Single-lab GFP-fusion evidence\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Mapped substrate specificity (P2 leucine preference, distributed hemoglobin cleavage) and the active-site plasticity distinguishing FP2A from falcipain-3, informing inhibitor design.\",\n      \"evidence\": \"Positional-scanning libraries, 18O-labeling cleavage mapping, MS-based hemoglobin digestion, and E-64 co-crystal structure\",\n      \"pmids\": [\"19357776\", \"19128015\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological ordering of hemoglobin cleavage in vivo not established\", \"Contribution of exo-site to cleavage-site selection not deconvolved\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended the inhibitor repertoire by resolving an ICP (chagasin-like) inhibitor bound to FP2A, revealing a distinct binding mode.\",\n      \"evidence\": \"X-ray crystallography of PbICP-C:FP2A complex at 2.6 Å\",\n      \"pmids\": [\"21742259\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of ICP–FP2A regulation in vivo not addressed\", \"Inhibitor is a P. berghei protein bound to P. falciparum FP2A\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the molecular determinants of autoactivation, showing specific salt bridges and hydrophobic prodomain–mature-domain contacts are required for autoprocessing.\",\n      \"evidence\": \"Mutagenesis, circular dichroism, and trans-activation assays on recombinant FP2A\",\n      \"pmids\": [\"23077573\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo requirement of these residues not tested\", \"Single-lab in vitro system\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placed FP2A within an ~200-kDa food-vacuole complex coupling hemoglobin degradation to hemozoin formation, integrating proteolysis with heme detoxification.\",\n      \"evidence\": \"Co-IP/MS, gel filtration, glycerol gradient co-sedimentation, and in vitro hemoglobin-to-hemozoin reconstitution\",\n      \"pmids\": [\"23471987\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and spatial organization of the complex undefined\", \"Whether complex assembly is required for activity in vivo unclear\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified heme as an allosteric inhibitor of FP2A via an inducible binding site, suggesting product feedback regulation of hemoglobin digestion.\",\n      \"evidence\": \"Enzyme kinetics, porphyrin analogue SAR, and docking/molecular dynamics\",\n      \"pmids\": [\"25791019\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding site identified computationally, not crystallographically\", \"Physiological significance of the feedback not demonstrated in parasites\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked reduced FP2A enzymatic activity from natural polymorphisms to increased ring-stage survival, connecting FP2A function to artemisinin sensitivity.\",\n      \"evidence\": \"Full-length sequencing of 140 isolates, haplotype-based activity assays, and ring-stage survival assays\",\n      \"pmids\": [\"29659945\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between hemoglobin digestion and artemisinin activation not directly demonstrated\", \"Single-lab functional haplotype analysis\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed a PTEX-dependent step in FP2A trafficking, indicating translocation into the parasitophorous vacuole en route to the food vacuole.\",\n      \"evidence\": \"Conditional PTEX150 knockdown, GFP-fusion lines, Co-IP, and hemoglobin digestion assays\",\n      \"pmids\": [\"37523385\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanism of FP2A passage through PTEX unresolved\", \"Single-lab conditional knockdown\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The precise coupling between FP2A hemoglobin catabolism, heme handling within the ~200-kDa complex, and artemisinin activation remains mechanistically unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of FP2A bound to hemoglobin or within the food-vacuole complex\", \"In-parasite necessity of autoactivation residues and heme-feedback site untested\", \"Molecular mechanism of PTEX-mediated FP2A translocation unknown\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004197\", \"supporting_discovery_ids\": [0, 18]},\n      {\"term_id\": \"GO:0004175\", \"supporting_discovery_ids\": [0, 1, 14]},\n      {\"term_id\": \"GO:0030946\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020020\", \"supporting_discovery_ids\": [0, 8, 9]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0020002\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0044254\", \"supporting_discovery_ids\": [0, 1, 2, 14]},\n      {\"term_id\": \"GO:0044728\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0006508\", \"supporting_discovery_ids\": [0, 18]}\n    ],\n    \"complexes\": [\n      \"~200-kDa food-vacuole hemoglobin-degradation complex containing FP2A, heme detoxification protein, and plasmepsins [#13]\",\n      \"FP2A:falstatin inhibitory complex [#12]\",\n      \"FP2A:PbICP-C (chagasin-like inhibitor) complex [#15]\",\n      \"FP2A:cystatin complex [#5]\"\n    ],\n    \"partners\": [\n      \"Heme detoxification protein (HDP) [#13]\",\n      \"Falstatin (endogenous cysteine protease inhibitor) [#12]\",\n      \"ICP / PbICP-C (chagasin-like inhibitor) [#15]\",\n      \"PTEX components including PTEX150 [#20]\"\n    ],\n    \"other_free_text\": [\n      \"Active-site catalytic triad C42, H174, N204; C99/C119 structurally important; S149 for peptide substrate interaction [#18]\",\n      \"C-terminal beta-hairpin exo-site FP2(arm) mediates active-site-independent hemoglobin binding; deletion abolishes hemoglobinase activity [#3, #5]\",\n      \"N-terminal FP2(nose) motif required for prodomain-independent folding [#5]\",\n      \"Prodomain is a potent reversible competitive inhibitor (Ki ~10^-10 M), not a folding chaperone [#7]\",\n      \"Autoactivation requires salt bridges Arg185-Glu221 and Glu210-Lys403 and hydrophobic residues Phe214, Trp449, Trp453 [#16]\",\n      \"Synthesized as a membrane-bound zymogen; autocatalytic processing precedes food-vacuole delivery; bipartite prodomain trafficking motif [#8, #10]\",\n      \"Strong P2 leucine substrate preference; distributed hemoglobin cleavage [#14]\",\n      \"Heme binds 1:1 and allosterically inhibits activity via an inducible site adjacent to the catalytic center [#17]\",\n      \"Reduced FP2A activity from Southeast Asian polymorphisms associated with increased ring survival / decreased artemisinin sensitivity [#19]\",\n      \"Small-molecule inhibitor structures reveal active-site (E-64) and non-active-site binding pockets, including a cathepsin K-like allosteric site [#6, #21, #22]\",\n      \"In vitro cleaves erythrocyte membrane skeletal proteins ankyrin and protein 4.1 [#11]\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1115700","name":null,"product":"cysteine proteinase falcipain 2a","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"FP2A","evaluation":null}